Biochemical contact lens for treating photoablated corneal tissue
US5932205A · kind A · utility
Inventors
Key dates
| Filing date | Jul 24, 1997 |
| Grant date | Aug 3, 1999 |
| Priority date | — |
| Expiry date | Jul 24, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating photoablated corneal tissue are described. The methods include contacting photoablated corneal tissue with a contact lens which includes an amniotic composition such that scarring of the photoablated corneal tissue is reduced. Methods for conditioning a contact lens for treatment of photoablated corneal tissue are also described. The methods include contacting the contact lens with an amniotic composition whereby the amniotic composition is deposited in or on the surface of said contact lens. Additionally, contact lens packages for treatment of photoablated corneal tissue are described. The contact lens package includes a container holding a contact lens which includes an amniotic composition and instructions for using the contact lens for treatment of photoablated corneal tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.